PMLS - The Home of
ZERO is the HERO!

What Do We Mean?

Making Medicare, LMSAs, as well as Lien issues DISAPPEAR or get MASSIVELY REDUCED to the lowest rock-bottom amount that is reasonable and defensible.

That is what we mean by

ZERO IS THE HERO!

MSA Initial Consult Overview

In the video below, Jack Meligan, Founder of THE PLAINTIFF’S MSA AND LIEN SOLUTION, answers many of the questions that are covered during one of those initial consult calls –

If after watching this video you have any further questions related to the specific terms and conditions of your case – call us and let us help you avoid any Medicare issues that could hinder and slow down your settlement.

888-MSA-PLTF (888-672-7583).

Medicare
Problems
Solved

Medicare and Lien Problems in Settlement are a Drag
We solve Medicare and lien problems for plaintiffs.
  • We help Top Trial Lawyers eliminate the Hassle, Headache, Worry, Expense, and Liability of dealing with their clients’ Medicare, Medicare Conditional Payment, Medicaid and other lien problems. (See 3 Problems You Must Solve for Your Medicare Clients – www.plaintiffsmsa.com/3-medicare-problems-every-trial-attorney-must-solve-clients).
  • To focus on more productive tasks and recapture the joy of why you became a trial lawyer, choose one of the Next Step Options below:
  • #1 Submit: Email your case-related question to us and one of PMLS' problem solvers will respond – info@plaintiffsmsa.com
  • #2 Hand Off: your case for our specialized services HERE.
  • #3 Call: For a no-charge consultation, give us a call – 888-MSA-PLTF or 888-672-7583.
– The PMLS Team

Need to free yourself from Medicare, Medicaid, Medicare Conditional Payment or ERISA Liens? The PLAINTIFF’S MSA AND LIEN SOLUTION
will handle it. ALL OF IT.

We are Professionals Who Get It. Our team handles Medicare problems, and we are experts at resolving Medicaid, Conditional Payment and ERISA liens.

We save you time, and we save your clients money.
We are PMLS. Your Medicare Problems Solved.
Protecting Plaintiffs from Medicare Issues.